This is the subject from my article today Evidence baseA fraction is down:
On May 12, 2025, President Trump issued an executive order for the “most preferred nation” (MFN) drug pricing in the US. The main questions you include:
▪ What is MFN pricing?
▪ Which countries will be included in the MFN basket?
▪ How low drug prices are in East-US vs. America?
▪ How should I evaluate MFN? What is the overall goal of drug pricing?
▪ Why do drug prices vary by the country? Is this a good thing?
▪ What has happened when other countries have implemented international reference pricing?
Let us answer each of these questions one by one. I have included some major readings to help motion fast on the issue.
Head on full article on full article to find my reactions for each of these questions (with significant additional readings) Evidence base Here.
